Additional Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Philadelphia PA. 19140
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Trois RiviEres G8T 7A1
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    New York NY. 10065
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Ajax L1S 2J5
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Albany NY. 12208
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Jacksonville FL. 32224
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Cypress CA. 77429
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Nashville TN. 37204
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Saint John's A1B 3V6
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Ann Arbor MI. 48109-5360
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Rochester NY. 55905
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Move With Air: Physiological Response Assessment

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • Move With Air: Exercise Training Study

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    Temple University
    Philadelphia PA. 19140
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    Temple University Hospital
    Philadelphia PA. 19140
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    University of Alberta Hospital (University of Alberta)
    Edmonton AB. T6G 1Z1
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    St. Paul's Hospital
    Vancouver BC. V1Y 1S1
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    Dartmouth-Hitchcock Medical Center
    Lebanon NH. 03756
    View Details

  • A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550

    Mayo Clinic, Rochester
    Rochester MN. 55905
    View Details